Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Abivax (ABVX) EBIT Margin (2022 - 2025)

Historic EBIT Margin for Abivax (ABVX) over the last 2 years, with Q3 2025 value amounting to 102.85%.

  • Abivax's EBIT Margin rose 4093800.0% to 102.85% in Q3 2025 from the same period last year, while for Sep 2025 it was 264.2%, marking a year-over-year change of. This contributed to the annual value of 1389.54% for FY2024, which is 13669200.0% up from last year.
  • As of Q3 2025, Abivax's EBIT Margin stood at 102.85%, which was up 4093800.0% from 886.14% recorded in Q2 2025.
  • Abivax's EBIT Margin's 5-year high stood at 142.06% during Q4 2024, with a 5-year trough of 886.14% in Q2 2025.